Completed
First-in-Human Trial of Oral AN2-502998
NCT07024589
- Conditions
- Chagas Disease, Euglenozoa Infections, Healthy Volunteers, +5 more
- Locations
-
- Nucleus Network Melbourne, Victoria, Australia